6th Global Pharma SFE Forum

Fleming Europe15 - 16 March 2011, Lisbon, Portugal.
Following the previous five successful SFE conferences, Fleming Europe announced the 6th Pharma SFE Forum. The conventional conference program has been changed to interactive simulation games, case studies discussions, panel and round table sessions. Global Pharma SFE Forum is focused solely on interaction between attendees and expert presenters.

The 2 Focused Streams (Sales, Marketing, CRM, HR, and Training) will consist of Hands-on Case Studies, Workshops, Simulation presentations and Panel discussions.

Case Studies:

  • Detect Recent Trends and Future of Commercial Model
  • Targeting Effectiveness with right Metrics
  • How to Enjoy Change? Challenge of Merger- Acquisition Process
  • Where do you Spend your Promotional Dollar?
  • Using Marketing Simulation to Drive Brand Awareness
  • Innovative Approaches for Creative Marketing and Increasing Sales Trough Diverse, Multi Channel Initiatives
  • Hiring Pharma Sales Reps: Getting the Process Right
  • The Evolving Training Needs of Pharma Sales Force
  • What they "do" they learn: Most Effective Training For Your Sales Force "Simulation Gaming"
  • Achieving a CRM project success
  • Sales Territory Analysis and Optimization
  • Overcoming Restricted Access to Physicians
  • Using Technology to achieve sales force effectiveness
  • Determining Sales Force Size
  • Motivating and Compensating the Sales Force
  • Discovering Proven Methods to Measure the Impact of your Incentives
  • Value your Sales Talents, Cultural Differences

Workshops:

  • Use the opportunity to interact with presenters face-to-face to ask your questions and brainstorm with your peers.

Keynote:

  • Brand-New Holistic Approach of Pharmaceutical Sales Model

Fleming Europe has gathered almost 20 Vice Presidents, Global Heads and Senior Directors. A special part is an evening event to discover Lisbon and enjoy its finest spring hour.

For further information and registration, please visit:
http://www.sfeforum.com

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

BioMotiv and Bristol-Myers Squibb announce the lau…

BioMotiv, a mission-driven drug development accelerator associated with The Harrington Project for discovery and development, that advances breakthrough discoveries from ...

CEPI and GSK announce collaboration to strengthen …

CEPI, the Coalition for Epidemic Preparedness Innovations, and GSK announced a new collaboration aimed at helping the global effort to develop a vaccine for the 2019-nCoV...

Sandoz completes acquisition of Aspen's Japanese o…

Sandoz today announced that it has successfully completed the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen ...

Sanofi brain-penetrant BTK inhibitor meets primary…

The Sanofi Phase 2b study evaluating its investigational BTK (Bruton's tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieve...

Roche reports very strong results in 2019

In 2019, Group sales rose 9% to CHF 61.5 billion and core EPS grew 13%, ahead of sales. The core operating profit increased 11%, reflecting the strong underlying business...

Sanofi completes acquisition of Synthorx, Inc.

Sanofi announced the successful completion of its acquisition of Synthorx, Inc. ("Synthorx") for $68 per share in cash. "The acquisition of Synthorx perfectly aligns w...

Merck donates one billionth praziquantel tablet

Merck, a leading science and technology company, today announced that it has already donated 1 billion tablets of praziquantel, the standard medication for the treatment ...

WHO, China leaders discuss next steps in battle ag…

The Director-General of the World Health Organization (WHO), Dr Tedros Adhanom Ghebreyesus, met President Xi Jinping of the People's Republic of China in Beijing. They sh...

Bayer and Nuvisan create new research unit in Berl…

Bayer AG today announced that it entered into a definitive agreement to transfer a large part of its Berlin-based small molecule research unit to Nuvisan, an internationa...

FDA approves first drug for treatment of peanut al…

Today the U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, tha...

Can bilingualism protect the brain even with early…

A study by York University psychology researchers provides new evidence that bilingualism can delay symptoms of dementia. Alzheimer's disease is the most common form of d...

Poliovirus therapy shows potential as cancer vacci…

A modified form of poliovirus, pioneered at Duke Cancer Institute as a therapy for glioblastoma brain tumors, appears in laboratory studies to also have applicability for...